Wei Jin
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Oncology top 5%
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
Papers in
-
- DNA Repair Mechanisms 5
- Ubiquitin and proteasome pathways 5
- RNA modifications and cancer 5
- Epigenetics and DNA Methylation 4
- Oncology 26
- Cancer Cells and Metastasis 6
- Co-authors
- Hefen Sun (29 shared papers)Liangdong Li (15 shared papers)Jiong Wu (10 shared papers)Shuiping Gao (11 shared papers)Yang Zhao (14 shared papers)Wenyan Fu (7 shared papers)Zhi‐Ming Shao (3 shared papers)Xianjun Yu (5 shared papers)
- Journals
- Breast Cancer Research and Treatment (5 papers)Cancer Medicine (5 papers)Acta Biochimica et Biophysica Sinica (5 papers)Oncogene (3 papers)Oncotarget (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Wei Jin
69 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 93
- Cancer Research 421
- Oncology 489
- Molecular Biology 909
- Immunology 161
- Pulmonary and Respiratory Medicine 188
Countries citing papers authored by Wei Jin
This map shows the geographic impact of Wei Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Jin more than expected).
Fields of papers citing papers by Wei Jin
This network shows the impact of papers produced by Wei Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Jin. The network helps show where Wei Jin may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 225 | |
| 2 | 2017 | 140 | |
| 3 | 2012 | 100 | |
| 4 | 2009 | 91 | |
| 5 | 2019 | 76 | |
| 6 | 2015 | 59 | |
| 7 | 2022 | 45 | |
| 8 | 2012 | 44 | |
| 9 | 2019 | 43 | |
| 10 | 2018 | 43 | |
| 11 | 2018 | 42 | |
| 12 | 2018 | 42 | |
| 13 | 2015 | 40 | |
| 14 | 2015 | 39 | |
| 15 | 2009 | 35 | |
| 16 | 2021 | 33 | |
| 17 | 2008 | 29 | |
| 18 | 2018 | 28 | |
| 19 | 2013 | 27 | |
| 20 | 2019 | 27 |
About Wei Jin
Wei Jin is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Genetics, having authored 72 papers that have together received 1.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (6 papers), Cancer Cells and Metastasis (6 papers), Cancer-related molecular mechanisms research (6 papers), Cancer, Hypoxia, and Metabolism (6 papers), DNA Repair Mechanisms (5 papers), Ubiquitin and proteasome pathways (5 papers), RNA modifications and cancer (5 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Cancer Research (421 citations), Oncology (489 citations), Molecular Biology (909 citations), Immunology (161 citations) and Pulmonary and Respiratory Medicine (188 citations). Wei Jin has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Hefen Sun, Liangdong Li, Jiong Wu, Shuiping Gao, Yang Zhao, Wenyan Fu, Zhi‐Ming Shao, Xianjun Yu, Chun-Tao Wu and He-Li Gao. Their work appears in journals such as Breast Cancer Research and Treatment, Cancer Medicine, Acta Biochimica et Biophysica Sinica, Oncogene and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.